ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
US Tech 100
17,658.00
0.32%
Dow Jones
39,387.76
0.85%
Brent Oil
84.235
0.34%
Bitcoin
62,867.64
-0.29%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/10/20242:20AMAlliance NewsAlliance NewsTOP NEWS: UK GDP grows ahead of consensus in March and first quarter
05/10/20242:15AMPR Newswire (US)Novavax Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
05/10/20242:15AMPR Newswire (US)Sanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations
05/10/20242:09AMGlobeNewswire Inc.INDICATEURS TRIMESTRIELS DE CMT AU 31 MARS 2024 • Chiffre d’affaires en progression et poursuite de la baisse de l’endettementEU:ALAMGAuplata Mining Group
05/10/20242:05AMBusiness WireCRH Continues Share Buyback ProgramNYSE:CRHCRH Plc
05/10/20242:00AMAlliance NewsAlliance NewsIN BRIEF: Genedrive aims to raise at least GBP6 million in share offerLSE:GDRGenedrive Plc
05/10/20242:00AMGlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19BIT:SANFSanofi
05/10/20242:00AMGlobeNewswire Inc.Record de volume traité 137 KtEU:ALAMGAuplata Mining Group
05/10/20242:00AMGlobeNewswire Inc.Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
05/10/20242:00AMGlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesBIT:1SANSanofi
05/10/20242:00AMBusiness WireShionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
05/10/20242:00AMGlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesTG:SNWSanofi
05/10/20242:00AMGlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesBIT:SANFSanofi
05/10/20242:00AMGlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesEU:SANSanofi
05/10/20242:00AMGlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19EU:SANSanofi
05/10/20242:00AMGlobeNewswire Inc.PGS Contract Award in West AfricaTG:PGS1PGS ASA
05/10/20242:00AMGlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19BIT:1SANSanofi
05/10/20242:00AMGlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesEU:SANSanofi
05/10/20242:00AMGlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19TG:SNWSanofi
05/10/20242:00AMBusiness WireCRH Q1 2024 ResultsNYSE:CRHCRH Plc
05/10/20242:00AMPR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:NVAXNovavax Inc
05/10/20242:00AMPR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:SNYSanofi
05/10/20241:55AMAlliance NewsAlliance NewsLONDON MARKET EARLY CALL: FTSE 100 called up on BoE hold, pre-UK GDP
05/10/20241:37AMAlliance NewsAlliance NewsGET READY: CRH, IAG, Rightmove, TBC Bank at 0700 BSTLSE:CRHCrh Plc
05/10/20241:37AMAlliance NewsAlliance NewsGET READY: CRH, IAG, Rightmove, TBC Bank at 0700 BSTLSE:CRHCrh Plc
05/10/20241:36AMAlliance NewsAlliance NewsAlliance News UK - start of day
05/10/20241:30AMGlobeNewswire Inc.VIEL & Cie : 1er trimestre 2024 : Croissance du chiffre d’affaires de 5,2% à 299,0 millions d’eurosEU:VILViel et Compagnie
05/10/20241:30AMGlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
05/10/20241:30AMGlobeNewswire Inc.Iveco Group 2024 First Quarter ResultsBIT:IVGIveco Group NV
05/10/20241:30AMGlobeNewswire Inc.VIEL & Cie : 1er trimestre 2024 : Croissance du chiffre d’affaires de 5,2% à 299,0 millions d’eurosLSE:0HZWViel Et Compagnie Sa

Your Recent History

USOTC
TXTM
ProText Mobility (PK)
USOTC
EMGE
Emergent Health (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
RDAR
Raadr (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
CLNV
Clean Vision (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
GSTC
Globestar Therapeutics (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
ERHE
ERHC Energy (CE)
USOTC
BABL
Buildablock (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved